Mohammad Reza Moghaddasnejad: Platelet Activation as a Key Driver of Breast Cancer Progression
Mohammad Reza Moghaddasnejad, Hematology and Oncology Researcher, shared a post on LinkedIn:
“Breast cancer cells alter platelet biology.
Breast cancer cells influence platelet biology through multiple mechanisms.
These cells secrete interleukin-6 (IL-6), which stimulates the liver to increase the production of thrombopoietin (TPO).
Elevated levels of TPO promote megakaryocyte maturation in the bone marrow, leading to an increased number of circulating platelets in patients.
In addition, tumor cells release various soluble factors and exosomes that act on peripheral blood platelets, altering their transcriptome and proteome.
These alterations generate a platelet phenotype that actively contributes to the progression of breast cancer.
Moreover, breast cancer cells participate in platelet activation by directly interacting with platelets and secreting tissue factor (TF), which induces thrombin generation and facilitates the platelet activation process.
In their direct interaction with platelets, breast cancer cells express surface ligands such as podoplanin, mucin, CD44, and CD97, which bind to their respective receptors on platelets—including CLEC-2, CD62P, and integrin αIIbβ3—and play key roles in triggering platelet activation.”
Stay updated with Hemostasis Today.
-
Jun 4, 2026, 13:54Yaariv Khaykin: AI ECG Analysis Uncovers Hidden AF Associated With Future Stroke Risk
-
Jun 4, 2026, 13:50Gene Nudelman: Can a Hemostatic Gauze Perform When Blood Clotting is Impaired?
-
Jun 4, 2026, 13:45Edward Lee Carter: The First-Ever AHA/ACC Acute PE Guideline Is Here
-
Jun 4, 2026, 13:38Denis Oduor: The Role of Expectant Fathers in Saving Mothers and Newborns
-
Jun 4, 2026, 13:31Fredrick Chalinga: Microcytic Anemia Does Not Always Mean Iron Deficiency
-
Jun 4, 2026, 13:23How Access to Care Changed One Life – WFH
-
Jun 4, 2026, 13:16Muhammad Usman Arshad: Meta-Analysis Supports Expanding Role of DOACs in Cancer-Associated Thromboembolism
-
Jun 4, 2026, 12:59Dual Prognostic Significance of P2RY12 in Antithrombotic-Treated STEMI – JTH
-
Jun 4, 2026, 12:43Beth Wallace: Raising Awareness of Hereditary Haemochromatosis